At a glance
- Originator Pfizer
- Class Antihypertensives
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 02 Aug 2000 No-Development-Reported for Congestive heart failure in USA (Unknown route)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 06 Nov 1998 New profile